These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 610938)

  • 21. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Field trial of a heat-stable measles vaccine in Papua New Guinea.
    Climie A; André FE
    J Trop Med Hyg; 1984 Dec; 87(6):249-55. PubMed ID: 6534989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serological evidence of persistent elimination of measles in Czechoslovakia].
    Strauss J; Svandová E; Smelhausová M; Mrázová M
    Cas Lek Cesk; 1989 Mar; 128(13):399-403. PubMed ID: 2790867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody titres after measles vaccine.
    Ghosh S; Kumari S; Bhargava SK
    Indian J Med Res; 1977 Aug; 66(2):165-71. PubMed ID: 924590
    [No Abstract]   [Full Text] [Related]  

  • 33. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the effectiveness of vaccination against measles with and areactogenic vaccine].
    Boĭchuk LM; Kozlova NA; Smorodinova IP; Petrova TN; Desiatova SA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():96-101. PubMed ID: 4808390
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 38. [Measles].
    Gasnier JL
    Soins; 1979 May; 24(10):3-9. PubMed ID: 256636
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of neutralizing antibodies against measles virus in Indians of Xingu, Central Brazil].
    Baruzzj RG; Rodrigues MC; Carvalho RP; de Souza-Dias LC
    Rev Inst Med Trop Sao Paulo; 1971; 13(5):356-62. PubMed ID: 5162259
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on the subclinical infection of the recipients of measles vaccine].
    Wu T; Wang SL; Xiang YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):70-2. PubMed ID: 8758397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.